KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Assets Average (2016 - 2026)

AbbVie has reported Assets Average over the past 13 years, most recently at $133.9 billion for Q4 2025.

  • Quarterly Assets Average fell 3.85% to $133.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $133.9 billion through Dec 2025, down 3.85% year-over-year, with the annual reading at $134.6 billion for FY2025, 0.28% changed from the prior year.
  • Assets Average was $133.9 billion for Q4 2025 at AbbVie, down from $135.5 billion in the prior quarter.
  • Over five years, Assets Average peaked at $150.5 billion in Q1 2021 and troughed at $133.9 billion in Q4 2025.
  • The 5-year median for Assets Average is $140.9 billion (2022), against an average of $141.0 billion.
  • Year-over-year, Assets Average skyrocketed 66.97% in 2021 and then fell 6.01% in 2025.
  • A 5-year view of Assets Average shows it stood at $147.7 billion in 2021, then fell by 5.17% to $140.1 billion in 2022, then dropped by 3.28% to $135.5 billion in 2023, then rose by 2.82% to $139.3 billion in 2024, then decreased by 3.85% to $133.9 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Assets Average are $133.9 billion (Q4 2025), $135.5 billion (Q3 2025), and $136.7 billion (Q2 2025).